Bausch Health, Salix Pharmaceuticals and Alfasigma SpA filed a patent infringement lawsuit against Sandoz, a division of Novartis.
Exact Sciences’ week started with a boom when the FDA expanded its approval for the company’s noninvasive colon cancer test Cologuard to include the 45 to 49 age range. Cologuard President Mark Stenhouse elaborated on what the indication means to the company: Read more.
Lakewood Ranch-based Florida Digestive Health Specialists added Avantika Mishra, MD, to its team.
Switzerland-based immuno-transcriptomics company Novigenix SA said its blood-based colorectal cancer test delivered encouraging results.
Takeda Pharmaceutical Co. is exploring a deal to sell several of its over-the-counter and prescription drugs in emerging markets and Western Europe.
The FDA cleared six new Fujifilm Medical Systems, U.S.A. endoscopic products.
Gastroenterology-focused pharmaceutical company Phantom Pharmaceuticals will appoint Terrie Curran as CEO after Celgene Corp. is acquired by Bristol-Myers Squibb.
Takeda and Evotec SE entered into a multiyear partnership to develop new drug therapies.
More articles on surgery centers:
ASC supply chain tip of the day: Use an inventory module
3 ways to ensure smooth adoption of new ASC technology
NTT Data, Tenet partner to deliver technology services
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.